Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Cancer Research - United States
doi 10.1158/0008-5472.can-12-1248
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2012
Authors
Publisher
American Association for Cancer Research (AACR)